- Home
- APLS vs FORM Comparison
APLS vs FORM Comparison
Compare APLS & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- FORM
- Stock Information
- Founded
- APLS 2009
- FORM 1993
- Country
- APLS United States
- FORM United States
- Employees
- APLS N/A
- FORM N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- FORM Semiconductors
- Sector
- APLS Health Care
- FORM Technology
- Exchange
- APLS Nasdaq
- FORM Nasdaq
- Market Cap
- APLS 3.3B
- FORM 2.9B
- IPO Year
- APLS 2017
- FORM N/A
- Fundamental
- Price
- APLS $18.20
- FORM $25.19
- Analyst Decision
- APLS Buy
- FORM Buy
- Analyst Count
- APLS 18
- FORM 8
- Target Price
- APLS $45.59
- FORM $48.00
- AVG Volume (30 Days)
- APLS 2.8M
- FORM 1.1M
- Earning Date
- APLS 05-06-2025
- FORM 04-30-2025
- Dividend Yield
- APLS N/A
- FORM N/A
- EPS Growth
- APLS N/A
- FORM N/A
- EPS
- APLS N/A
- FORM 0.89
- Revenue
- APLS $781,367,000.00
- FORM $763,599,000.00
- Revenue This Year
- APLS $12.71
- FORM $4.29
- Revenue Next Year
- APLS $20.93
- FORM $7.08
- P/E Ratio
- APLS N/A
- FORM $28.30
- Revenue Growth
- APLS 97.02
- FORM 15.16
- 52 Week Low
- APLS $17.49
- FORM $22.58
- 52 Week High
- APLS $53.06
- FORM $63.63
- Technical
- Relative Strength Index (RSI)
- APLS 28.14
- FORM 38.94
- Support Level
- APLS $18.00
- FORM $22.58
- Resistance Level
- APLS $19.71
- FORM $27.95
- Average True Range (ATR)
- APLS 1.63
- FORM 2.23
- MACD
- APLS -0.16
- FORM 0.14
- Stochastic Oscillator
- APLS 10.98
- FORM 34.62
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.